KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Amortization - Intangibles: 2009-2025

Historic Amortization - Intangibles for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Sep 2025 value amounting to $168.4 million.

  • Jazz Pharmaceuticals' Amortization - Intangibles rose 6.93% to $168.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $639.2 million, marking a year-over-year increase of 3.10%. This contributed to the annual value of $627.3 million for FY2024, which is 3.13% up from last year.
  • Jazz Pharmaceuticals' Amortization - Intangibles amounted to $168.4 million in Q3 2025, which was up 9.01% from $154.4 million recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Amortization - Intangibles registered a high of $172.1 million during Q1 2022, and its lowest value of $68.2 million during Q1 2021.
  • In the last 3 years, Jazz Pharmaceuticals' Amortization - Intangibles had a median value of $155.1 million in 2023 and averaged $155.8 million.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Amortization - Intangibles skyrocketed by 152.37% in 2022 and then dropped by 12.96% in 2023.
  • Jazz Pharmaceuticals' Amortization - Intangibles (Quarterly) stood at $157.3 million in 2021, then declined by 12.66% to $137.4 million in 2022, then grew by 10.31% to $151.6 million in 2023, then climbed by 4.85% to $158.9 million in 2024, then increased by 6.93% to $168.4 million in 2025.
  • Its Amortization - Intangibles was $168.4 million in Q3 2025, compared to $154.4 million in Q2 2025 and $158.9 million in Q4 2024.